Chemistry and chemical biology of taxane anticancer agents

Chemical Records

Volumn 1, Issue 3, 2001, Pages 195-211

  Miller, Michael L ^a   Ojima, Iwao ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Common pharmacophore; Macrocyclic hybrids; Taxane anticancer agents; Taxoids; lsm

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; DRUG DERIVATIVE; GLYCOPROTEIN P; PACLITAXEL; TAXOID;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG RESISTANCE; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; REVIEW; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MODELS, MOLECULAR; P-GLYCOPROTEIN; PACLITAXEL; STRUCTURE-ACTIVITY RELATIONSHIP; TAXOIDS;

EID: 0035756986     PISSN: 15278999     EISSN: None     Source Type: Journal    
DOI: 10.1002/tcr.1008     Document Type: Article

References (98)

1. Georg, G. L; Chen, T. T.; Ojima, I.; Vyas, D. M. Taxane Anticancer Agents: Basic Science and Current Status; American Chemical Society: Washington DC, 1995.
2. SufTness, M. Taxol: Science and Applications; CRC Press: New York, 1995.
3. Rowinsky, E. K.; Onetto, N.; Canetta, R. M.; Arbuck, S. G. Sem One 1992, 19,646.
4. Rowinsky, E. K. Ann Rev Med 1997, 48, 353.
5. Wani, M. C.; Taylor, H. L.; Wall, M. E.; Coggon, P.; McPhail, A. T. J Am Chem Soc 1971, 93, 2325.
6. Guénard, D.; Guéritte-Vogelein, F.; Potier, P. Ace Chem Res 1993, 26, 160.
7. Shifï, P. B.; Fant, J.; Horwitz, S. B. Nature 1979, 277, 665.
8. ShifF, P. B.; Horwitz, S. B. Proc NatI Acad Sei USA 1980, 77, 1561.
9. Vallée, R. B. In Taxol: Science and Applications; SufFness, M., editor; CRC Press: New York, 1995; p 259.
10. Ringel, I.; Horwitz, S. B. J Natl Cancer Inst 1991, 83, 288.
11. Denis, J.-N.; Greene, A. E.; Guénard, D.; Guéritte-Voegelein, E; Mangatal, L; Potier, P. J Am Chem Soc 1988, 110, 5917.
12. Holton, R. A.; Biediger, R. J.; Boatman, P. D. In Taxol: Science and Applications; SufFness, M., editor; CRC Press: New York, 1995; p 97.
13. Holton, R. A. US Patent 5,175,315, 1991.
14. Ojima, L; Habus, I.; Zhao, M.; Zucco, M.; Park, Y. H.; Sun, C.-M.; Brigaud, T. Tetrahedron 1992, 48, 6985.
15. Ojima, I.; Sun, C. M.; Zucco, M.; Park, Y. H.; Duclos, O.; Kuduk, S. D.Tet Lett 1993, 34, 4149.
16. Commerçon, A.; Bourzat.J. D.; Didier, E.; Lavelle, E In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G.I.; Chen, T.T.; Ojima, L; Vyas, D.M., editors; American Chemical Society: Washington, DC, 1995; p 233.
17. Kingston, D. G. L; Chaudhary, A. G.; Gunatilaka, A. A. L.; Middleton, M. L. Têt Lett 1994, 35, 4486.
18. Georg, G. L; Harriman, G. C. B.; Vander Velde, D. G.; Böge, T. C.; Cheruvallath, Z.S.; Datta, A.; Hepperle, M.; Park, H.; Himes, R. H.; Jayasinghe, L. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. L; Chen, T. T.; Ojima, L; Vyas, D. M., editors; American Chemical Society: Washington DC, 1995; p 217.
19. [ 19] Kingston, D. G. I. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. L; Chen, T. T; Ojima, L; Vyas, D. M. editors; American Chemical Society: Washington, DC, 1995; p 203.
20. Klein, L. L.; Li, L; Yeung, C. M.; Maring, C. J.; Thomas, S. A.; Grampovnik, D. J.; Plattner, J. J. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G.I.; Chen, T.T.; Ojima, L; Vyas, D.M., editors; American Chemical Society: Washington, DC, 1995; p 276.
21. Ojima, I.; Park, Y. H.; Fenoglio, I.; Duclos, O.; Sun, C.-M; Kuduk, S. D.; Zucco, M.; Appendino, G.; Pera, P.; Veith, J. M.; Bernacki, R. J.; Bissery, M.-C.; Combeau, C.; Vrignaud, P.; Riou, J. F.; Lavelle, F. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, L; Vyas, D. M., editors; American Chemical Society: Washington, DC, 1995; p 262.
22. Holton, R. A.; Somoza, C.; Kim, H.-B.; Liang, F.; Biediger, R. J.; Boatman, P. D.; Shindo, M.; Smith, C. C.; Kim, S.; Nadizadeh, H.; Suzuki, Y.; Tao, C.; Vu, P.; Tang, S.; Zhang, P.; Murthi, K. K.; Gentile, L. N.; Liu, J.H. J Am Chem Soc 1994, 116,1597.
23. Holton, R. A.; Kim, H.-B.; Somoza, C.; Liang, F.; Biediger, R. J.; Boatman, P. D.; Shindo, M.; Smith, C. C.; Kim, S.; Nadizadeh, H.; Suzuki, Y; Tao, C.; Vu, P.; Tang, S.; Zhang, P.; Murthi, K. K.; Gentile, L. N.; Liu, J. H. J Am Chem Soc 1994, 116, 1599.
24. Nicolaou, K. C.; Yang, Z.; Liu, J. J.; Ueno, H.; Nantermet, P. G.; Guy, R.K.; Claiborne, C. F.; Renaud, J.; Couladouros, E. A.; Paulvannan, K.; Sorensen, E. J. Nature 1994, 367, 630.
25. Danishefsky, S.; Masters, J.; Young, W; Link, J.; Snyder, L.; Magee, T.; Jung, D.; Isaacs, R.; Bornmann, W; Alaimo, C.; Coburn, C.; Di Grandi, M. J Am Chem Soc 1996, 118, 2843.
26. Wender, P. A.; Badham, N. F.; Conway, S. P.; Floreancig, P. E.; Glass,T. E.; Houze, J. B.; Krauss, N. E.; Lee, D.; Marquess, D. G.; McGrane, P. L.; Meng, W; Natchus, M. G.; Shuker, A. J.; Sutton, J. C.;Taylor, R. E. J Am Chem Soc 1997, 119, 2757.
27. Ojima, I. in Proceedings of the Chiral '93 USA Symposium; Spring Innovation Ltd., 1993; p. 49.
28. Ojima, I. Chimica Oggi, 1993, 11(9)9.
29. Ojima, I. Ace Chem Res 1995, 28, 383.
30. Ojima, L; Slater, J. C.; Michaud, E.; Kuduk, S. D.; Bounaud, P.-Y; Vrignaud, P.; Bissery, M.-C.; Veith, J.; Pera, P.; Bernacki, R. J. J Med Chem 1996, 39, 3889.
31. Ojima, L; Kuduk, S. D.; Slater, J. C.; Gimi, R. H.; Sun, C. M.; Chakravarty, S.; Ourevich, M.; Abouabdellah, A.; Bonnet-Delpon, D.; Bègue, J.-P.; Veith, J. M.; Pera, P.; Bernacki, R. J. In Biomédical Frontiers of Fluorine Chemistry; Ojima L; McCarthy J. R.; Welch, J. T. editors; ACS Symp. Ser. 639; American Chemical Society: Washington, DC, 1996; p 228.
32. Ojima, L; Slater, J. S.; Kuduk, S. D.; Takeuchi, C. S.; Gimi, R. H.; Sun, C.-M.; Park, Y. H.; Pera, P.; Veith, J. M.; Bernacki, R. J. J Med Chem 1997, 40, 267.
33. Ojima, L; Kuduk, S. D.; Pera, P.; Veith, J. M.; Bernacki, R. J. J Med Chem 1997,40,279.
34. Ojima, L; Slater, J. C.; Fera, P.; Veith, J. M.; Abouabdellah, A.; Bègue, J.-P.; Bernacki, R. J. Bioorg Med Chem Lett 1997, 7, 209.
35. Ojima, I.; Slater, J. C. Chirality 1997, 9, 487.
36. Ojima, I. US Patent 5,294,737, 1994.
37. Ojima, L; Park, Y. H.; Sun, C. M.; Brigaud, T.; Zhao, M. Tet Lett 1992, 33, 5737.
38. Ojima, I. In Advances in Asymmetrie Synthesis, Vol. 1; Hassner, A., editor; JAI Press: Greenwich, 1995; p 95.
39. Ojima, L; Delaloge, F. Chcm Soc Rev 1997, 26, 377.
40. Ojima, I.; Lin, S.-, Wang, T. Gurr Med Chem 1999, 6, 927.
41. [4l] Ojima, I.; Kuduk, S. D.; Chakravarty, S. AdvMed Chem 1999, 4,69.
42. The standard five human cancer cell lines used in these studies are: A121 (ovarian), A549 (NSCL), HT-29 (colon), MCF7 (breast), and a doxorubicin drug-resistant cell line MCF7-MDR (breast).
43. Georg, G. L; Böge, T. C.; Cheruvallath, Z. S.; Glowers, J. S.; Harriman, G. C. B.; Hepperle, M.; Park, H. InTaxoP: Science and Applications; CRC Press: New York, 1995; p 317.
44. Kant, J.; O'Keeffe, W. S.; Chen, S.-H.; Farina, V.; Fairchild, C.; Johnston, K.; Kadow, J. F.; Long, B. H.; Vyas, D. Tet Lett 1994, 35, 5543.
45. Chen, S.-H.; Fairchild, C; Mamber, S. W.; Farina, V. J Org Chem 1993, 58, 2927.
46. Kirschner, L. S.; Greenberger, L. M.; Hsu, S. I.-H.; Yang, C.-P. H.; Cohen, D.; Piekarz, R. L.; Castillo, G.; Han, E. K.-H. H.; Yu, L; Horwitz, S. B. Biochem Pharm 1992, 43, 77.
47. Gottesman, M. M.; Pastan, I. Ann Rev Biochem 1993,62,385.
48. Sikic, B. I. J Clin Oncol 1993, 11, 1629.
49. Ferlini, C.; Distefano, M.; Pignatelli, F.; Lin, S.; Riva, A.; Bombardelli, E.; Mancuso, S.; Ojima, L; Scambia, G. Brit J Cancer 2000, 83,1762.
50. Ojima, L; Duclos, D.; Dormân, G.; Simonot,.B.; Prestwich, G. D.; Rao, S.; Lerro, K. A.; Horwitz, S. B. J Med Chem 1995, 38,3891.
51. Bounaud, P.-Y.; Ojima, I. Syntheses of new photoreactive analogs of paclitaxel; 212th American Chemical Society National Meeting, Orlando, FL, August 1996, Abstracts, ORGN 0073.
52. Bounaud, P.-Y.; Ojima, I.; Ahern, D.; Orr, G.; Horwitz, S. B. New Paclitaxel Photoaffininty Labels to Probe the Binding Site on the Multidrug Transporter P-Glycoprotein, 215th American Chemical Society National Meeting, Dallas, TX, March 1998, Abstracts, MEDI 000.
53. Ojima, I.; Bounaud, P.; Takeuchi, C. S.; Pera, P.; Bernacki, R. J. Bioorg Med Chem Lett 1998, 8, 189.
54. Böge, T. C.; Hirnes, R. H.; Vander Velde, D. G.; Georg, G. I. J Med Chem 1994, 37, 3337.
55. Ojima, L; Bounaud, P.; Bernacki, R. J. Chemtech 1998, 28,31.
56. Ojima, L; Bounaud, R; Bernacki, R. J. Mod Drug Disc 1999, May/June, 45.
57. Chakravarty, S.; Ojima, I. Taxoid and Non-taxoid Inhibitors of Microtubule Disassembly: Molecular Modeling Approach to Elucidation of a Common Pharmacophore, The 214th American Chemical Society National Meeting, Las Vegas, NV, Sept. 1997, Abstracts, MEDI 075.
58. Chaudary, A. G.; Gharpure, M. M.; Rimoldi, J. M.; Chordia, M. D.; Gunatilaka, A.A.L.; Kingston, D. G. I.; Grover, S.; Lin, C. M.; Hamel, E. J. J Am Chem Soc 1994, 116, 4097.
59. Kingston, D. G. I.; Chaudary, A. G.; Chordia, M. D.; Gharpure, M. M.; Gunatilaka, A. A. L.; Higgs, P. I.; Rimoldi, J. M.; Samala, L.; Jagtap, P. G.; Giannakakou, P.; Jiang, Y. Q.; Lin, C. M.; Hamel, E. J.; Long, B. H.; Fairchild, C. R.; Johnston, K. A. J Med Chem 1998,41,3715.
60. Ojima, I.; Wang, T.; Miller, M. L; Lin, S.; Borella, C. P.; Geng, X.; Fera, P.; Bernacki, R. J. BioMed Chem Lett 1999, 9, 3423
61. Appendino, G.; Gariboldi, P.; Gabetta, B.; Pace, R.; Bombar- delli, E.; Viterbo, D. J Chem Soc Perkins Trans l 1992, 2925.
62. Kant, J.; Farina, V.; Fairchild, C.; Kadow, J. F.; Langley, D. R.; Long, B. H.; Rosé, W. C.; Vyas, D. M. Bioorg Med Chem Lett 1994,4,1565.
63. Vuilhorgne, M.; Gaillard, C.; Sanderlink, G. J.; Royer, I.; Monsarrat, B.; Dubois, J.; Wright, M. In Taxane Anticancer Agents: Basic Science and Current Status; Georg G. L; Chen, T. T.; Ojima, I.; Vyas, D. M., editors; ACS Sym Series 583; American Chemical Society: Washington DC, 1995; p 98.
64. Monsarrat, B.; Mariel, E.; Gros, S.; Garés, M.; Guénard, D.; Guéritte-Voegelein, F.; Wright, M. Drug Metab Dispos 1990, 18,895.
65. Filler, R.; Kobayashi, Y.; Yagupolskii, L. M. Organofluorine Compounds in Medicinal Chemistry and Biomédical Applications, Vol. 48; Elsevier: Amsterdam, 1993.
66. Ojima, I.; Kuduk, S. D.; Chakravarty, S.; Ourevitch, M.; Bègue, J.-P.J Am Chem Soc 1997, 119,5519.
67. Gilchrist, L.; McDermott, A.; Ojima, L; Kuduk, S. D.; Walsh, J. J.; Chakravarty, S.; Orr, G.; Horwitz, S. B. Unpublished results.
68. Rao, S.; Horwitz, S. B.; Ringel, I. J Natl Cancer Inst 1992, 84, 785.
69. Rao, S.; Krauss, N. E.; Heerding, J. M.; Swindell, C. S.; Ringel, L; Orr, G. A.; Horwitz, S. B. J Biol Chem 1994, 269,3132.
70. Rao, S.; Orr, G. A.; Chaudhary, A. G.; Kingston, D. G. L; Horwitz, S. B. J Biol Chem 1995, 270, 20235.
71. Rao, S.; He, L.; Chakravarty, S.; Ojima, L; Orr, G. A.; Horwitz, S. B. J Bio Chem 1999, 274, 37990.
72. Nogales, E.; Wolf, S. G.; Downing, K. H. Nature 1998, 391, 199.
73. Yoshimura, A.; Kuwazuru, Y.; Sumizawa, T.; Ichikawa, M.; Ikeda, S.-L; Uda, T.; Akiyama, S.-I. J Biol Chem 1989, 264, 16282.
74. Greenberger, L. M.; Lisanti, C. J.; Silva, J. T.; Honvitz, S. B. Biol Chem 1991, 266, 20744.
75. Bruggemann, E. P.; Germann, U. A.; Gottesman, M. M.; Pastan, I. J Biol Chem 1989, 264, 15483.
76. Jordan, M.A.; Toso, R.J.; Wilson, L. Proc Natl Acad Sei USA 1993, 90, 9552.
77. Bollag, D.M.; McQueney, P.A.; Zhu, J.; Hensens, O.; Koupal, L.; Liesch, J.; Goetz, M.; Lazarides, E.; Woods, C.M. Cancer Res 1995, 55, 2325.
78. Kowalski, R.J.; Giannakakou, P.; Hamel, E. J Biol Chem 1997, 272, 2534.
79. Lindel.T.; Jensen, P.R.; Fenical, W; Long, B.H.; Casazza, A.M.; Carboni, J.; Fairchild, C.R. J Am Chem Soc 1997, 119, 8744.
80. ter Haar, E.; Kowalski, R.J.; Hamel, E.; Lin, C.M.; Longley, R.E.; Gunasekera, S.P.; Rosenkranz, H.S.; Day, B.W. Biochemistry 1996, 35, 243.
81. Kowalski, R.J.; Giannakakou, P.; Gunasekera, S.P.; Longley, R.E.; Day, B.W.; Hamel, E. Mol Pharmacol 1997, 52, 613.
82. Giannakakou, P.; Sacke, D.L.; Kang, Y.; Zhan, Z.; Buters, J.T.M.; Fojo, T.; Poruchynsky, M.S. J Biol Chem 1997, 272, 17118.
83. Kowalski, R.J.; ter Haar, E.; Longley, R.E.; Gunasekera, S.P.; Lin, CM.; Day, B.W.; Hamel, E. Mol Biol Cell 1995,6,368a.
84. Hung, D.T.; Chen, J.; Schreiber, S.L. Chem Biol 1996,3, 287.
85. Ojima, I.; Kuduk, S. D.; Chakravarry, S. Adv Med Chem 1999, 4. 96.
86. Ojima, I.; Inoue, T.; Chakravarty, S. J Fluor Chem 1999, 97,3.
87. Ojima, I.; Chakravarty, S.; Inoue, T.; Lin, S.; He, L.; Horwitz, 5. B.; Kuduk, S.; Danishefsky, S. J. Proc Natl Acad Sei USA 1999, 96, 4256.
88. Su, D.; Balog, A.; Meng, D.; Bertinato, P.; Danishefsky, S.J.; Zheng, Y.; Chou, T.; He, L.; Horwitz, S.B. Angew Chem Int EdEngll997,36,2093.
89. Chou, T.; Zhang, X.; Balog, A.; Su, D.; Meng, D.; Savin, K.; Bertino, J.R.; Danishefsky, S.J. Proc Natl Acad Sei USA 1998, 95, 9642.
90. Chou, T.C.; Zhang, X.G.; Harris, C.R.; Kuduk, S.D.; Balog, A.; Savin,K.;Danishefsky,SJ.ProcNatlAcadSci 1998,95,15798.
91. McDaid, H.M.; Bhattacharya, S.K.; Chen, S.; He, L.; Shen, H.; Gutteridge, C.E.; Horwitz, S.B.; Danishefsky, S.J. Cancer Chemother Pharmacol 1998, 44, 131.
92. Ojima, L; Lin, S.; Inuoe, T.; Miller, M. L; Borella, C. R; Geng, X.; Walsh, J. J.; J Chem Soc 2000, 122, 5353.
93. Schuster, M.; Siegfried, B. Angew Chem Int Ed Eng 1997, 36, 2036.
94. Furstner, A. Top Catal 1997, 4, 285
95. Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413.
96. Schwab, P.; France, M. B.; Ziller, J. W.; Grubbs, R. H. Angew Chem Int Ed Eng 1995, 34, 2039.
97. Furstner, A.; Langemann, K. Synthesis 1997, 792.
98. Miller, M. L; Geng, X.; Lin, S.; Ojima, L; Fera, P.; Bernacki, R. J. Design, Synthesis, and Biological Activity of Novel Macrocy-clic Taxoids as Potential Anticancer Agents: 219th ACS National Meeting, San Francisco, CA, August 1999, Abstr. MEDI 40.